Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial - Florea, Viorel G.; Rector, Thomas S.; Anand, Inder S.; Cohn, Jay N. (Circulation. Heart failure, 2016)
Keywords: Adrenergic beta-Antagonists - therapeutic use; Aged; Angiotensin II Type 1 Receptor Blockers - adverse effects; Angiotensin II Type 1 Receptor Blockers - therapeutic use; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Biomarkers - blood; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Failure - diagnostic imaging; Heart Failure - drug therapy; Heart Failure - mortality; Heart Failure - physiopathology; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mineralocorticoid Receptor Antagonists - therapeutic use; Recovery of Function; Stroke Volume - drug effects; Time Factors; Treatment Outcome; Valsartan - adverse effects; Valsartan - therapeutic use; Ventricular Function, Left - drug effects; blood pressure; heart failure; valsartan; biomarker; prognosis